BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 9774404)

  • 1. Activation of factor VIII by thrombin increases its affinity for binding to synthetic phospholipid membranes and activated platelets.
    Saenko EL; Scandella D; Yakhyaev AV; Greco NJ
    J Biol Chem; 1998 Oct; 273(43):27918-26. PubMed ID: 9774404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of factor VIIIa A2 and A3-C1-C2 subunits to the affinity for factor IXa in factor Xase.
    Jenkins PV; Dill JL; Zhou Q; Fay PJ
    Biochemistry; 2004 May; 43(17):5094-101. PubMed ID: 15109268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and functional characterization of platelet receptor-mediated factor VIII binding.
    Ahmad SS; Scandura JM; Walsh PN
    J Biol Chem; 2000 Apr; 275(17):13071-81. PubMed ID: 10777612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replacing the factor VIII C1 domain with a second C2 domain reduces factor VIII stability and affinity for factor IXa.
    Wakabayashi H; Fay PJ
    J Biol Chem; 2013 Oct; 288(43):31289-97. PubMed ID: 24030831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of surface plasmon resonance for studies of protein-protein and protein-phospholipid membrane interactions. Application to the binding of factor VIII to von Willebrand factor and to phosphatidylserine-containing membranes.
    Saenko E; Sarafanov A; Greco N; Shima M; Loster K; Schwinn H; Josic D
    J Chromatogr A; 1999 Aug; 852(1):59-71. PubMed ID: 10480230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slowed release of thrombin-cleaved factor VIII from von Willebrand factor by a monoclonal and a human antibody is a novel mechanism for factor VIII inhibition.
    Saenko EL; Shima M; Gilbert GE; Scandella D
    J Biol Chem; 1996 Nov; 271(44):27424-31. PubMed ID: 8910322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of thrombin-activated human factor VIII.
    Curtis JE; Helgerson SL; Parker ET; Lollar P
    J Biol Chem; 1994 Feb; 269(8):6246-51. PubMed ID: 8119969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the C2 domain of factor VIIIa in the assembly of factor-X activating complex on the platelet membrane.
    Ahmad SS; Walsh PN
    Biochemistry; 2005 Oct; 44(42):13858-65. PubMed ID: 16229474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cleavage of factor VIII light chain is required for maximal generation of factor VIIIa activity.
    Regan LM; Fay PJ
    J Biol Chem; 1995 Apr; 270(15):8546-52. PubMed ID: 7721754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic stability and functional properties of disulfide bond-stabilized coagulation factor VIIIa variants.
    Gale AJ; Radtke KP; Cunningham MA; Chamberlain D; Pellequer JL; Griffin JH
    J Thromb Haemost; 2006 Jun; 4(6):1315-22. PubMed ID: 16706977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of factor VIIIa and factor VIII to factor IXa on phospholipid vesicles.
    Duffy EJ; Parker ET; Mutucumarana VP; Johnson AE; Lollar P
    J Biol Chem; 1992 Aug; 267(24):17006-11. PubMed ID: 1512239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor VIII lacking the C2 domain retains cofactor activity in vitro.
    Wakabayashi H; Griffiths AE; Fay PJ
    J Biol Chem; 2010 Aug; 285(33):25176-84. PubMed ID: 20529839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of activation of the coagulation factor VIII in interaction with vWf, phospholipid, and functioning within the factor Xase complex.
    Saenko EL; Shima M; Sarafanov AG
    Trends Cardiovasc Med; 1999 Oct; 9(7):185-92. PubMed ID: 10881749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The factor VIII C1 domain contributes to platelet binding.
    Hsu TC; Pratt KP; Thompson AR
    Blood; 2008 Jan; 111(1):200-8. PubMed ID: 17916745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of A1 subunit residue Q316 in thrombin-activated factor VIII to A2 subunit dissociation.
    Parker ET; Lollar P
    Biochemistry; 2007 Aug; 46(34):9737-42. PubMed ID: 17676877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulant properties of hybrid human/porcine factor VIII molecules.
    Lollar P; Parker ET; Fay PJ
    J Biol Chem; 1992 Nov; 267(33):23652-7. PubMed ID: 1429706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural investigation of zymogenic and activated forms of human blood coagulation factor VIII: a computational molecular dynamics study.
    Venkateswarlu D
    BMC Struct Biol; 2010 Feb; 10():7. PubMed ID: 20184747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FVIII binding to PS membranes differs in the activated and non-activated form and can be shielded by annexin A5.
    Engelke H; Lippok S; Dorn I; Netz RR; Rädler JO
    J Phys Chem B; 2011 Nov; 115(44):12963-70. PubMed ID: 21954889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The acidic region of the factor VIII light chain and the C2 domain together form the high affinity binding site for von willebrand factor.
    Saenko EL; Scandella D
    J Biol Chem; 1997 Jul; 272(29):18007-14. PubMed ID: 9218428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor IXa enhances reconstitution of factor VIIIa from isolated A2 subunit and A1/A3-C1-C2 dimer.
    Lamphear BJ; Fay PJ
    J Biol Chem; 1992 Feb; 267(6):3725-30. PubMed ID: 1740424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.